In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Recursion Pharmaceuticals (RXRX) shares have been drawing ...

Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 174.14M to 173.93M. This put 35.4% of the company's publicly available shares ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

Malicious telnyx 4.87.1/4.87.2 on PyPI used audio steganography March 27, 2026, enabling cross-platform credential theft.

Infosecurity outlines key recommendations for CISOs and security teams to implement safeguards for AI-assisted coding ...

过去一两年，ChatGPT 等 AI 聊天工具凭借强大信息处理能力，成为工作中的 “万能顾问”，高效搞定写邮件、解疑问等需求。但面对业务执行场景，它们暴露短板：仅能提供方案，缺乏行动力、无法集成内部系统、难串联复杂流程，始终是 ...